{"id":790,"date":"2019-09-26T14:38:49","date_gmt":"2019-09-26T14:38:49","guid":{"rendered":"https:\/\/hosting.uantwerpen.be\/valuedx\/?p=790"},"modified":"2023-03-15T10:39:26","modified_gmt":"2023-03-15T10:39:26","slug":"790","status":"publish","type":"post","link":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/","title":{"rendered":"Launch of VALUE-Dx"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-jzkylawd-ba86e75d702405f62001a756eb35483d\">\n.avia-section.av-jzkylawd-ba86e75d702405f62001a756eb35483d{\nbackground-color:#08b4a0;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-jzkylawd-ba86e75d702405f62001a756eb35483d main_color avia-section-default avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  avia-bg-style-parallax container_wrap fullsize'  ><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-790'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k13ftv8v-a32fd2b84d9de6fe43a5035450090922\">\n#top .av-special-heading.av-k13ftv8v-a32fd2b84d9de6fe43a5035450090922{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-k13ftv8v-a32fd2b84d9de6fe43a5035450090922 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-k13ftv8v-a32fd2b84d9de6fe43a5035450090922 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-k13ftv8v-a32fd2b84d9de6fe43a5035450090922 av-special-heading-h3 blockquote modern-quote modern-centered  avia-builder-el-1  el_before_av_codeblock  avia-builder-el-first '><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >University of Antwerp, bioM\u00e9rieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n\n\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1cjng-9db903d36b325f87b66fb9ba7e96614e\">\n.avia-section.av-1cjng-9db903d36b325f87b66fb9ba7e96614e{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_2'  class='avia-section av-1cjng-9db903d36b325f87b66fb9ba7e96614e main_color avia-section-default avia-no-border-styling  avia-builder-el-3  el_after_av_section  el_before_av_section  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-790'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0\">\n.flex_column.av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0{\nborder-radius:0px 0px 0px 0px;\npadding:50px 5% 50px 5%;\n}\n<\/style>\n<div  class='flex_column av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0 av_one_full  avia-builder-el-4  el_before_av_one_fifth  avia-builder-el-first  first flex_column_div  '     ><section  class='av_textblock_section av-yfjs-a24130328363a5d48e40d9c86a7bb2c6 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p><strong>Antwerp (Belgium), London (UK), Marcy l\u2019Etoile (France) \u2013 April 1, 2019 &#8211; <\/strong>The University of Antwerp, bioM\u00e9rieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six <em>in vitro<\/em> diagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. The purpose of VALUE-Dx is to transform medical practice to achieve more personalised, evidence-based antibiotic prescription and use in community care settings through the widespread use of clinical and cost-effective innovative diagnostic strategies. VALUE-Dx is co-funded by the European Commission (IMI), the Wellcome Trust and private companies, with a total budget of around 14 million euros over 4 years.<\/p>\n<p>Diagnostics are deemed instrumental in guiding health care professionals in treating infectious diseases. However, in community care settings antibiotics are often overused and unnecessarily prescribed, accelerating AMR. VALUE-Dx is a European-wide approach to generate evidence on the medical, economic, and public health value of diagnostics in tackling AMR. It will focus on acute respiratory tract infections acquired in community care settings as they are the most frequent cause of medical consultation and inappropriate antibiotic use. The outcomes of VALUE-Dx could apply to other common infections such as urinary tract infections, blood stream infections, and hospital-acquired respiratory tract infections.<\/p>\n<p>According to Dr. Pierre Meulien, Executive Director, Innovative Medicines Initiative (IMI), <em>\u201cDiagnostics are an essential element in the fight against AMR. I am delighted that IMI is supporting a project that, for the first time, has been conceived by representatives of the diagnostics sector and includes world renowned \u00a0experts from a wide range of academic disciplines. Only by pooling expertise and working together in this way can we hope to address major challenges like AMR\u201d.<\/em><\/p>\n<p><em>\u00a0\u201cVALUE-Dx is a unique multidisciplinary consortium, with participation of clinicians, microbiologists, health economists, social scientists, and industry\u201d<\/em>, states Professor Dr. Goossens of the University of Antwerp and leader of this project. <em>\u201cIt should help to build the medical and economic case for rapid diagnostics as a public good in the fight against antibiotic resistance\u201d.<\/em><\/p>\n<p><em>\u201cWellcome is very excited to support this European project\u201d<\/em>, says Tim Jinks of Wellcome Trust. \u201c<em>Diagnostics are an essential tool to help us tackle AMR, but in order to realise their full potential, we need to be using them much more widely than we currently are. Community care settings are often the first point of care for many people with common infectious diseases, and better use of diagnostics in these settings could significantly reduce unnecessary prescribing of antibiotics. The VALUE-Dx project will allow us to develop\u00a0deep understanding of the economic, regulatory and policy value determinants of medical diagnostics and help\u00a0drive the uptake of innovative diagnostic tools into everyday clinical use\u201d.<\/em><\/p>\n<p><em>\u201cDiagnostic tests provide actionable information that are instrumental to enable reasonable use of antimicrobials\u201d<\/em>, explains Mark Miller, Executive Vice President and Chief Medical Officer at bioM\u00e9rieux. <em>\u201cThe diagnostic industry has a key role to play in the battle against AMR, and together we will be stronger to fight this global public health threat. We are convinced that the VALUE-Dx project will be a game changer to show the true medical and economic value of diagnostics to support antibiotic stewardship and preserve the efficacy of these medications for improving patient care today and for future generations\u201d.<\/em><\/p>\n<p>The VALUE-Dx kick-off meeting is taking place in Madrid, Spain, from April 1 to April 4 and brings together major stakeholders and key experts in the field of diagnostics and AMR.<\/p>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-3b8mw-b506a38e8d00a7f4906eea669cebc6be\">\n.flex_column.av-3b8mw-b506a38e8d00a7f4906eea669cebc6be{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-3b8mw-b506a38e8d00a7f4906eea669cebc6be av_one_fifth  avia-builder-el-6  el_after_av_one_full  el_before_av_one_fifth  first flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5\">\n.flex_column.av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5 av_one_fifth  avia-builder-el-7  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-7tlo-f8416bb2afc61a4a130355b19410e269\">\n.flex_column.av-7tlo-f8416bb2afc61a4a130355b19410e269{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-7tlo-f8416bb2afc61a4a130355b19410e269 av_one_fifth  avia-builder-el-8  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><div  class='av-social-sharing-box av-k0i4kjks-6d3450111d8e25130dca06d4190760bd av-social-sharing-box-minimal  avia-builder-el-9  avia-builder-el-no-sibling  av-social-sharing-box-fullwidth'><div class=\"av-share-box\"><ul class=\"av-share-box-list noLightbox\"><li class='av-share-link av-social-link-twitter avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on X\" href='https:\/\/twitter.com\/share?text=Launch%20of%20VALUE-Dx&#038;url=https:\/\/www.value-dx.eu\/?p=790' data-av_icon='\ue932' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on X'><span class='avia_hidden_link_text'>Share on X<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href='https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=Launch%20of%20VALUE-Dx&#038;url=https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/' data-av_icon='\ue8fc' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on LinkedIn'><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail avia_social_iconfont' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=Launch%20of%20VALUE-Dx&#038;body=https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/' data-av_icon='\ue805' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1gk3g-e035d72a73a93486e640208771f4a074\">\n.flex_column.av-1gk3g-e035d72a73a93486e640208771f4a074{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-1gk3g-e035d72a73a93486e640208771f4a074 av_one_fifth  avia-builder-el-10  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-yzdo-63e3a9df4e270ed0fd52b6929706fb26\">\n.flex_column.av-yzdo-63e3a9df4e270ed0fd52b6929706fb26{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-yzdo-63e3a9df4e270ed0fd52b6929706fb26 av_one_fifth  avia-builder-el-11  el_after_av_one_fifth  avia-builder-el-last  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i590fy-427634ed8909a6d2106239c938ad0962\">\n.avia-section.av-k0i590fy-427634ed8909a6d2106239c938ad0962{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_3'  class='avia-section av-k0i590fy-427634ed8909a6d2106239c938ad0962 main_color avia-section-default avia-no-border-styling  avia-builder-el-12  el_after_av_section  el_before_av_codeblock  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-790'><div class='entry-content-wrapper clearfix'>\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='after_section_3'  class='main_color av_default_container_wrap container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-790'><div class='entry-content-wrapper clearfix'>\n\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>University of Antwerp, bioM\u00e9rieux, and Wellcome Trust<br \/>\nto coordinate VALUE-Dx, a European Public-Private Partnership<br \/>\nto fight antimicrobial resistance through diagnostics<\/p>\n","protected":false},"author":152,"featured_media":808,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[21],"class_list":["post-790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-launch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Launch of VALUE-Dx - value-dx<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Launch of VALUE-Dx - value-dx\" \/>\n<meta property=\"og:description\" content=\"University of Antwerp, bioM\u00e9rieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/\" \/>\n<meta property=\"og:site_name\" content=\"value-dx\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-26T14:38:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-15T10:39:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1226\" \/>\n\t<meta property=\"og:image:height\" content=\"428\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Leandra\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:site\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Leandra\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/\"},\"author\":{\"name\":\"Leandra\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"headline\":\"Launch of VALUE-Dx\",\"datePublished\":\"2019-09-26T14:38:49+00:00\",\"dateModified\":\"2023-03-15T10:39:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/\"},\"wordCount\":1541,\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"keywords\":[\"launch\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/\",\"name\":\"Launch of VALUE-Dx - value-dx\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"datePublished\":\"2019-09-26T14:38:49+00:00\",\"dateModified\":\"2023-03-15T10:39:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"contentUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"width\":1226,\"height\":428},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2019\\\/09\\\/26\\\/790\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Launch of VALUE-Dx\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/\",\"name\":\"value-dx\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.value-dx.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\",\"name\":\"Leandra\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/author\\\/leandra\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Launch of VALUE-Dx - value-dx","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/","og_locale":"en_US","og_type":"article","og_title":"Launch of VALUE-Dx - value-dx","og_description":"University of Antwerp, bioM\u00e9rieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics","og_url":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/","og_site_name":"value-dx","article_published_time":"2019-09-26T14:38:49+00:00","article_modified_time":"2023-03-15T10:39:26+00:00","og_image":[{"width":1226,"height":428,"url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","type":"image\/png"}],"author":"Leandra","twitter_card":"summary_large_image","twitter_creator":"@ValueDx","twitter_site":"@ValueDx","twitter_misc":{"Written by":"Leandra","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#article","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/"},"author":{"name":"Leandra","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"headline":"Launch of VALUE-Dx","datePublished":"2019-09-26T14:38:49+00:00","dateModified":"2023-03-15T10:39:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/"},"wordCount":1541,"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","keywords":["launch"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/","url":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/","name":"Launch of VALUE-Dx - value-dx","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#primaryimage"},"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","datePublished":"2019-09-26T14:38:49+00:00","dateModified":"2023-03-15T10:39:26+00:00","author":{"@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"breadcrumb":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#primaryimage","url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","contentUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","width":1226,"height":428},{"@type":"BreadcrumbList","@id":"https:\/\/www.value-dx.eu\/index.php\/2019\/09\/26\/790\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.value-dx.eu\/index.php\/homepage\/"},{"@type":"ListItem","position":2,"name":"Launch of VALUE-Dx"}]},{"@type":"WebSite","@id":"https:\/\/www.value-dx.eu\/#website","url":"https:\/\/www.value-dx.eu\/","name":"value-dx","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.value-dx.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d","name":"Leandra","url":"https:\/\/www.value-dx.eu\/index.php\/author\/leandra\/"}]}},"jetpack_featured_media_url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/users\/152"}],"replies":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/comments?post=790"}],"version-history":[{"count":0,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/790\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media\/808"}],"wp:attachment":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media?parent=790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/categories?post=790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/tags?post=790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}